An early-onset, progressive disinhibition-like behavior has been reported in the P301S-tau mice using the elevated-plus maze [47] together with early NFT pathology in the CA3 region, resembling clinical presentations and neuropathology of bvFTD. The gene discussed is MAPT; the disease is behavioral variant of frontotemporal dementia.